4:44 pm Insmed to announces results from Phase 2 clinical trial for treatment resistant nontuberculous mycobacteria lung infections on Wednesday, March 26, at ~7:00 a.m. ET; to host conference call at 8:00 a.m. ET
moreView todays social media effects on INSMView the latest stocks trending across Twitter. Click to view dashboardSee who Insmed is hiring next, click here to view […]